ライフサイエンスコーパス: active immunization

1 b titers define protection in the setting of active immunization.

2 significantly increased with reinfection and active immunization.

3 successful strategy to develop a vaccine for active immunization.

4 ular effectors in the neutropenic host after active immunization.

5 opriate serologic testing and counseling for active immunization.

6 , significantly enhanced T cell responses to active immunization.

7 valuate potential vaccine candidates through active immunization.

8 tion was enhanced in SCI rats via passive or active immunization.

9 e quality of immune responses induced during active immunizations.

10 ng antibody responses, whether by passive or active immunization, a genotyping monitor will be necess

11 evaluated the basis for immunity induced by active immunization against a melanoma differentiation A

12 tive tumor immunity in models of passive and active immunization against a relevant tumor differentia

13 Successful active immunization against cancer requires induction of

14 that CSL is a rational target for passive or active immunization against cryptosporidiosis.

15 a candidate molecular target for passive or active immunization against cryptosporidiosis.

16 assive immunization with mAb against gp75 or active immunization against gp75 prevented the developme

17 ivable that an immunomodulatory strategy via active immunization against many of these antigens could

18 rpose of this study was to determine whether active immunization against pneumolysin (PLY), or polysa

19 w observations on the results of passive and active immunization against the antigens.

20 Active immunization against the beta-amyloid peptide (Al

21 Active immunization against the tumor-specific MAGE-A3 a

22 eventual expression of cancer Ags by LCs for active immunization against tumors.

23 Our data demonstrate that active immunization against VIP reduces neuronal recruit

24 e of the newly characterized oligomers as an active immunization agent targeting amyloid self- assemb

25 n wild-type mice an alternative approach for active immunization: an epitope vaccine that selectively

26 educed the duration and clinical severity of active immunization and adoptive transfer EAE.

27 early effector T cells, in combination with active immunization and IL-2, resulted in the eradicatio

28 fficacy of recombinant PotD was evaluated by active immunization and intravenous challenge with capsu

29 Recently, both active immunization and passive administration of A beta

30 mice are highly resistant to EAE induced by active immunization, and this resistance appears to be m

31 ing viral antigens may be useful for in vivo active immunization as well as ex vivo priming of cytoto

32 ollowing primary infection, reinfection, and active immunization, as well as immune protection in mic

33 e receptor (CCR)2, did not develop EAE after active immunization but generated effector cells that co

34 We conclude that CD28 licenses active immunization by regulating Ag-induced immunoregul

35 Active immunization can be performed using either the im

36 e in BMT patients is the first evidence that active immunization can reduce morbidity due to herpesvi

37 virus-neutralizing antibodies, together with active immunization, can prevent development of the dise

38 After active immunization, clinical scores of corneas of the r

39 cells, or two injections 7 and 10 days after active immunization, completely blocked development of E

40 ired antibody following primary infection or active immunization demonstrated no significant alterati

41 Anti-TECK Ab, elicited in the female mice by active immunization, depleted the ovarian CD8alpha alpha

42 As we found with active-immunization EAE, neuroinflammation was greatly r

43 f SasX as a vaccine component in passive and active immunization efforts using mouse infection models

44 In immunoblots, sera from rabbits following active immunization elicited cross-reactive antibodies t

45 In active immunization experiments, 78% of mice immunized w

46 ntrast, engagement of OX40 in the setting of active immunization has potent adjuvant properties, lead

47 Finally, immunity can persist after active immunizations have ended.

48 After active immunization, high levels of protection were achi

49 y of disease were dramatically reduced after active immunization in complement-depleted rats.

50 ndritic cells (DC) as a cellular vaccine for active immunization in healthy volunteers and allogeneic

51 Little is known about the role of active immunization in suppressing undesirable immune re

52 of inducing tumor-specific immunity through active immunization in the absence of defined tumor-asso

53 opM was not protective, either by passive or active immunization, in inbred or outbred mice.

54 nhibition assays, passive immunizations, and active immunizations indicated that this outer membrane-

55 from mucosal SIV challenge in the setting of active immunization is more complex than previously reco

56 Induction of EAE through active immunization led to rapid and severe disease in a

57 We report that active immunization markedly reduces intracellular Abeta

58 and complete Freund's adjuvant (CFA)-evoked active immunization models compared to the reference SSA

59 The first was homogeneous, capable of active immunization (mouse intravenous 50% lethal dose,

60 Active immunization of AG6 mice with a modified DENV NS1

61 Together, these studies indicate that active immunization of cancer-prone individuals may resu

62 Active immunization of hamsters with E. coli membrane fr

63 suggest that intervention strategies such as active immunization of human immunodeficiency virus (HIV

64 to improve DC-based immunotherapy; i.e., the active immunization of humans with autologous DCs that h

65 oxidized low-density lipoprotein (oxLDL) and active immunization of hypercholesterolemic mice with ox

66 We have shown previously that active immunization of mice against the melanocyte diffe

67 Active immunization of mice with a combination of the A

68 Active immunization of mice with combinations of PNAG an

69 Active immunization of mice with liposomal complete-core

70 potential role in host-pathogen interaction, active immunization of mice with recombinant enolase fai

71 Active immunization of PDAPP mice with human amyloid bet

72 We studied the capacity of active immunization of rhesus monkeys with HIV-1 envelop

73 n (PLP) 139--151-specific T cells engaged by active immunization of SJL mice.

74 to address the effects of anti-amyloid-beta active immunization on neurite trajectories and the path

75 lenge, but there was no detectable effect of active immunization once the tumor was established.

76 optimal formulation of either a vaccine for active immunization or a polyclonal intravenous IgG or m

77 at S. aureus type 5 CP antibodies induced by active immunization or administered by passive immunizat

78 c T cells, either spontaneously or following active immunization or adoptive transfer, immune-mediate

79 potential of PNAG as a vaccine component for active immunization or as a target for passive antibody

80 ce with MP4 after induction of EAE either by active immunization or by adoptive transfer of activated

81 antibodies may be most efficacious following active immunization or passive administration.IMPORTANCE

82 f this Ab in mice, as a result of passive or active immunization, or by enforced expression of the SM

83 ivation can be elicited in viral infections, active immunization, or cancer immunotherapy, leading to

84 IL-6 deficiency in models of EAE induced by active immunization, passive transfer, T cell transfer,

85 ce of maternal antibody also interferes with active immunization, placing infants at risk for severe

86 Antibodies, through passive or active immunization, play a central role in prophylaxis

87 Passive and active immunization protected mice from pneumococcal car

88 nical response of cancer patients undergoing active immunization protocols.

89 Furthermore, active immunization reduced acute lung injury in a lung

90 Three separate studies, two involving active-immunization regimens and one involving a passive

91 In contrast, tumor immunity induced by active immunization requires Ag receptor-bearing CD4+ T

92 Active immunization resulted in higher serological total

93 Active immunization schedules are being developed to min

94 Together, these data reveal passive and active immunization strategies for prevention or therapy

95 There is an urgent need for active immunization strategies that, if administered sho

96 Thus, an active immunization strategy that targets an angiogenesi

97 Here, we show the beneficial effects of an active immunization strategy using the SEDI antigenic pe

98 Recent active immunization studies have raised the possibility

99 the inter-species cytokine as immunogen for active immunization (TISCAI) to induce anti-cytokine ant

100 Here, we investigated whether active immunization to promote clearance of Abeta from a

101 PLP) 139-151 peptide EAE model, we show that active immunizations using CFA but not CpG 1826/IFA as a

102 One notable difference from GN induced by active immunization was a T cell infiltration in the ren

103 In this study, active immunization was studied in neutropenic rats infe

104 Unlike passive immunization, active immunization, which is the foundation of vaccinol

105 everity, or histopathology of EAE induced by active immunization with 100 micro g of myelin oligodend

106 monoclonal antibody GNC92H2 was elicited by active immunization with a cocaine immunoconjugate and b

107 Active immunization with a mutant form of Hla (Hla(H35L)

108 Active immunization with a native preparation of HgbA (n

109 e immunization with Hla-specific antisera or active immunization with a nontoxigenic form of Hla sign

110 Here, we present that active immunization with a phosphorylated tau epitope, i

111 cal, and immununological responses following active immunization with a purified Porphyromonas gingiv

112 A clinical trial using active immunization with Abeta1-42 was suspended after a

113 immunotherapy for human Alzheimer's disease, active immunization with amyloid-beta 1-42 results in th

114 In conclusion, active immunization with an anti-endotoxin vaccine impro

115 Chronic serum sickness was induced by active immunization with apoferritin.

116 Animal models based on active immunization with bacterial or viral mimics, dire

117 Active immunization with CFA and pertussis toxin, a proc

118 Active immunization with conjugated types 5 and 8 capsul

119 iated mortality were effectively reversed by active immunization with dendritic cells treated with HM

120 treptococcal pyrogenic exotoxin A (SpeA), or active immunization with either wild-type or a nonfuncti

121 of murine WN virus infection, and the use of active immunization with envelope protein and passive tr

122 Active immunization with Escherichia coli-expressed reco

123 These data indicate that active immunization with genes encoding tumor-specific a

124 Active immunization with GNC-KLH produced approximately

125 Active immunization with GND-KLH produced a 76% decrease

126 lerated in a chronic serum sickness model by active immunization with heterologous apoferritin.

127 Active immunization with HMW-MAA mimics has been previou

128 Active immunization with homologous, but not heterologou

129 perimental autoimmune uveoretinitis (EAU) by active immunization with interphotoreceptor retinal bind

130 These data indicate that active immunization with LOS-based conjugates reduces th

131 Active immunization with M1 Sse significantly protects m

132 y Neisseria meningitidis can be prevented by active immunization with meningococcal polysaccharide or

133 Importantly, active immunization with MHC class II(+) APCs triggered

134 Active immunization with MntC was effective at reducing

135 toimmune encephalomyelitis (EAE) produced by active immunization with myelin oligodendrocyte glycopro

136 Upon EAE induction by active immunization with myelin oligodendrocyte glycopro

137 Active immunization with nontoxigenic Hla(H35L) or passi

138 Active immunization with OMVs or passive transfer of ser

139 These data demonstrate that active immunization with P6 results in the production of

140 rosinase-related protein-1 (Tyrp1; gp75) and active immunization with plasmid DNA encoding altered Ty

141 AICAR), in active and passive EAE induced by active immunization with PLP(139-151) or MOG(35-55) and

142 Active immunization with pneumococcal capsular polysacch

143 of ligature-induced periodontitis, and that active immunization with porphypain-2 appeared capable o

144 Active immunization with Porphyromonas gingivalis whole-

145 The prophylactic efficacy of active immunization with purified P. aeruginosa LPS was

146 ge and no evidence of protection afforded by active immunization with purified pilin.

147 Active immunization with recombinant P21 did not protect

148 Active immunization with recombinant SasX or passive imm

149 In a genetically humanized mouse model, active immunization with sE2 efficiently protected again

150 Active immunization with Streptococcus mutans glucan bin

151 Active immunization with the amyloid beta (A beta) pepti

152 e present study investigated the efficacy of active immunization with the C-terminal domain of alpha

153 The efficacy of active immunization with the cocaine immunogen GNC-keyho

154 neumococcal keratitis in the rabbit, whereas active immunization with the conserved protein virulence

155 Active immunization with the first 50 amino acids of the

156 Here, we tested the hypothesis that active immunization with the idiotype would evoke a poly

157 experimental autoimmune uveoretinitis after active immunization with the interphotoreceptor retinoid

158 Active immunization with this vaccine merits further inv

159 The alternative approach of active immunization with tumor Id can cure the disease i

160 We conclude that active immunization with tumor Id can induce a polyclona

161 charide (CP)-specific antibodies elicited by active immunization with vaccines composed of Staphyloco

162 ll mice were markedly resistant to EAE after active immunization, with drastically impaired recruitme